> > About us

About us

 

Based in St. Jean (Toulouse), France, Tesalys is a French manufacturer of equipment for the treatment of infectious waste on site. Toulouse, a global showcase of European industrial know-how, has brought Tesalys the elements necessary for the international development of its STERIPLUSTM technology.
With the STERIPLUSTM crusher-sterilizer, Tesalys has quickly become a leader in bio-contaminated waste treatment systems on the production site.
Tesalys is now present through a network of distributors in more than 90 countries on five continents..

 

Management team :

Miquel Lozano
Miquel Lozano
President
Founding partner
Sales and Marketing
LinkedIn Miquel Lozano

Jean-Michel Rodriguez
Managing Director
Founding Partner
Operations, Administration and Finances
Linked In Jean Michel Rodriguez

Emmanuel Hengl
Technical Director
Founding Partner
R&D, Technical
LinkedIn Emmanuel Hengl

 

Institutional support

TESALYS was supported in its development for the 2014-2017 period by the Occitanie Pyrénées-Méditerranée Region and the FEDER (European Regional Development Fund).

Tesalys benefited from the PassExport and Export Contracts of the Occitania region for carrying out international development actions.

 

TESALYS also benefited from Innovation and Seed Loans as well as Export Prospecting Insurance, BPIFRANCE devices
This financial support made it possible to intensify R & amp; D and IP efforts, recruit technical and commercial staff and carry out marketing and communication actions, in particular internationally.

Associated Partners

Other Partners

 

 

Associations and other links of interest

French Healthcare
ISWA
Aspec
medical expo
export-environmental
reseau-dirigeant

History

madeinfrance1992
Patrick Hengl and Miquel Lozano met for the first time
Exchanges regarding biohazardous waste treatment solutions

2012
Tesalys was set up
STERIPLUS™ 20 was developed

2013
STERIPLUS™ 40 was developed
Tesalys won the Midinvest 2013 award
First sales

2014
Tesalys relocated to new premises in St. Jean (Toulouse)
Round of financing – Equity investment by Entrepreneur Venture

2015
Jury’s prize at the Inn’Ovations 2015 awards
Approval in France by the Ministry of Health and the Ministry of Ecology and Sustainable Development (NF X 30-503)
Sales in around twenty countries

2016
Marco Polo prize
EY’s prize for entrepreneur of the year
STERIPLUSTM 80 was developed
TESALYS continues its development through an external growth operation with the acquisition of Sterishred

2017
Development of sales of the STERISHRED® 250 model
Business growth in Southeast Asia

2018
Fundraising (series B) – Entry into the capital of IXO PE and Sigma Gestion
Retirement of one of the founding partners, Patrick Hengl

2019
Investment in a new 1,500 m2 production unit in St. Jean (Toulouse)
“Export Category” winner of the CEO’s Business Challenges Trophy
Delivery of the first units of the STERISHRED® 700 model

2020
Relocation of all production to sites in the Toulouse region.
Tesalys joins French Healthcare

BUSINESS SECTORS

Laboratories / Research

Voir

Hospitals / Clinics

Voir

Medical Centers

Voir

Hemodialysis centers

Voir

Other Applications

Voir